Cite
Relationship of the oxidative damage biomarker 8-epiprostaglandin F2 to risk of lung cancer development in the Shanghai Cohort Study.
MLA
Yuan, Jian-Min, et al. “Relationship of the Oxidative Damage Biomarker 8-Epiprostaglandin F2 to Risk of Lung Cancer Development in the Shanghai Cohort Study.” Carcinogenesis, vol. 39, no. 7, July 2018, pp. 948–54. EBSCOhost, https://doi.org/10.1093/carcin/bgy060.
APA
Yuan, J.-M., Carmella, S. G., Wang, R., Tan, Y.-T., Adams-Haduch, J., Gao, Y.-T., & Hecht, S. S. (2018). Relationship of the oxidative damage biomarker 8-epiprostaglandin F2 to risk of lung cancer development in the Shanghai Cohort Study. Carcinogenesis, 39(7), 948–954. https://doi.org/10.1093/carcin/bgy060
Chicago
Yuan, Jian-Min, Steven G Carmella, Renwei Wang, Yu-Ting Tan, Jennifer Adams-Haduch, Yu-Tang Gao, and Stephen S Hecht. 2018. “Relationship of the Oxidative Damage Biomarker 8-Epiprostaglandin F2 to Risk of Lung Cancer Development in the Shanghai Cohort Study.” Carcinogenesis 39 (7): 948–54. doi:10.1093/carcin/bgy060.